TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001193125-26-093930
Filing date: Mar 5, 2026
Earliest execution date: Mar 3, 2026

Summary

Type

Sell

Net shares

-1,274

% of shares

-30.33%

Amount (USD)

$41,226

Insider confidence score

46.3 out of 100

Positive

  • Tax withholding obligation
  • Small sell amount (<$50K)

Negative

  • Large tax withholding sell (≥1% of shares)

Stock transactions

Transaction 1

Security

Ordinary Shares

Action

Exercise

Date

2026-03-03

Code

M

Net shares

+3,461.0

Acquired/Disposed

Acquired

Shares Owned Before

739.0

Shares Owned After

4,200.0

Transaction 2

Security

Ordinary Shares

Action

Sell

Date

2026-03-03

Code

S

Net shares

-1,274.0

Price per Share

$32.36

Amount (USD)

$41,226.51

Acquired/Disposed

Disposed

Shares Owned Before

4,200.0

Shares Owned After

2,926.0

Derivative Transactions

Transaction 1

Security

Restricted Share Units

Action

Exercise

Date

2026-03-03

Code

M

Net shares

-3,461.0

Acquired/Disposed

Disposed

Shares Owned Before

6,922.0

Shares Owned After

3,461.0

Filing's footnotes

1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

2. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.

3. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II.

4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.72 to $32.865, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.

5. Restricted share units were granted on March 3, 2023, with 3,461 vested on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 3,461 vesting on March 3, 2027.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.